Toll‐like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas
- 4 August 2009
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 128 (1pt2), e600-e611
- https://doi.org/10.1111/j.1365-2567.2008.03041.x
Abstract
P>Toll-like receptors (TLRs) are increasingly implicated in the pathogenesis of cancer. The present study describes TLR expression and function in healthy and malignant airway epithelial cells. The squamous cell carcinoma cell line Detroit-562 was compared with the healthy bronchial epithelial cell line NL-20 and primary human nasal epithelial cells (HNECs). TLR2, TLR3 and TLR5 were present in primary head and neck squamous cell carcinomas (HNSCCs). Consistent with this, Detroit-562 expressed TLR2, TLR3 and TLR5, whereas NL-20 expressed mainly TLR3 and HNECs expressed TLR2-5. In Detroit-562, Pam(3)CSK(4), poly(I:C) and flagellin, ligands for TLR2, TLR3 and TLR5, respectively, induced an up-regulation of intercellular adhesion molecule 1 (ICAM-1), an increase in interleukin (IL)-6 and IL-8 secretion and a decrease in cell viability. Additionally, poly(I:C) affected IL-1 beta production and the migratory behaviour of Detroit-562. NL-20 responded with a slight increase in IL-8 secretion upon poly(I:C) stimulation. Poly(I:C) induced a small increase in IL-1 beta, IL-6 and IL-8 production in HNECs, while Pam(3)CSK(4) increased viability. The TLR signalling was transcription-dependent, but the pathways involved differed among TLRs as well as cells. In Detroit-562, TLR2 and TLR5 activation was mediated via c-jun N-terminal kinase (JNK)-, p38-, phosphatidylinositol 3-kinase (PI3K)- and nuclear factor (NF)-kappa B-related pathways, while TLR3 was dependent on NF-kappa B. In NL-20, TLR3 signalled via p38, and in HNECs, NF-kappa B, JNK and extracellular signal-regulated kinase (ERK) appeared to be involved. We found that TLR agonists induced a robust response in HNSCCs, characterized by generation of inflammation and cell death. A similar response was not seen in normal epithelial cells. Thus, the TLR system should be considered an important target in future antitumour immunotherapy.Keywords
This publication has 40 references indexed in Scilit:
- Gene Expression of Endothelial Cells due to Interleukin-1 Beta Stimulation and Neutrophil TransmigrationEndothelium, 2008
- Listeria monocytogenes Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 SignalingCancer Research, 2007
- Translational Mini-Review Series on Toll-like Receptors:
Networks regulated by Toll-like receptors mediate innate and adaptive immunityClinical and Experimental Immunology, 2007
- Apoptotic Responses in Squamous Carcinoma and Epithelial Cells to Small-Molecule Toll-like Receptor Agonists Evaluated with Automated CytometrySLAS Discovery, 2006
- Toll-like receptors and innate immunityJournal of Molecular Medicine, 2006
- Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?British Journal of Cancer, 2006
- Toll-like receptors, inflammation and cancerSeminars in Cancer Biology, 2006
- Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosisLaboratory Investigation, 2005
- Transcriptional signaling by double-stranded RNA: role of TLR3Cytokine & Growth Factor Reviews, 2005
- ICAM‐1 expression and the soluble ICAM‐1 level for evaluating the metastatic potential of gastric cancerInternational Journal of Cancer, 2002